Select a community
All Communities
Home > Community Treatment Reports > Neurodex (quinidine/dextromethorphan) Treatment Report
What is Neurodex?

Neurodex is a combination of 30mg Dextromethorphan (found in cough medicine) and 30mg Quinidine made by Avanir Phamaceuticals. In a randomised, multicentre control trial the combination of these two agents was found to halve episodes of emotional lability relative to either agent alone. Read more...Click to read more below

Avanir's Neurodex site

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Emotional lability 3 0
disease-related symptoms 1 0

Mouse over the table for more information

Dosages

  daily
  2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Neurodex (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense
1 50% Expense: 50%
Course of treatment ended
1 50% Course of treatment ended: 50%

See all 2 patients who’ve stopped taking Neurodex

Duration See details about how long patients take this treatment ▼

Stopped Taking Neurodex

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 22, 2009.